vs
Esperion Therapeutics, Inc.（ESPR）与Shimmick Corp（SHIM）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Shimmick Corp的1.2倍（$168.4M vs $141.9M），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -10.1%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Shimmick Corp是一家总部位于美国的重型民用建筑企业，专注于水处理设施、交通系统、大坝工程、环境修复等关键公共基础设施的建造与升级，主要服务北美各级政府客户，承接各类复杂大型建筑项目。
ESPR vs SHIM — 直观对比
营收规模更大
ESPR
是对方的1.2倍
$141.9M
两年增速更快
ESPR
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $141.9M |
| 净利润 | — | $-4.4M |
| 毛利率 | — | 7.6% |
| 营业利润率 | 50.6% | -2.2% |
| 净利率 | — | -3.1% |
| 营收同比 | 143.7% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRSHIM
| Q4 25 | $168.4M | $141.9M | ||
| Q3 25 | $87.3M | $128.4M | ||
| Q2 25 | $82.4M | $122.1M | ||
| Q1 25 | $65.0M | $103.6M | ||
| Q4 24 | $69.1M | — | ||
| Q3 24 | $51.6M | $166.0M | ||
| Q2 24 | $73.8M | $90.6M | ||
| Q1 24 | $137.7M | $120.0M |
净利润ESPRSHIM
| Q4 25 | — | $-4.4M | ||
| Q3 25 | $-31.3M | $-8.5M | ||
| Q2 25 | $-12.7M | $-9.8M | ||
| Q1 25 | $-40.5M | $-38.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $-1.6M | ||
| Q2 24 | $-61.9M | $-51.4M | ||
| Q1 24 | $61.0M | $-33.3M |
毛利率ESPRSHIM
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 6.3% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | -20.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 7.3% | ||
| Q2 24 | — | -34.4% | ||
| Q1 24 | — | -13.2% |
营业利润率ESPRSHIM
| Q4 25 | 50.6% | -2.2% | ||
| Q3 25 | -11.4% | -5.5% | ||
| Q2 25 | 8.6% | -7.3% | ||
| Q1 25 | -34.0% | -39.3% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -31.0% | 0.7% | ||
| Q2 24 | 3.5% | -53.0% | ||
| Q1 24 | 52.5% | -26.5% |
净利率ESPRSHIM
| Q4 25 | — | -3.1% | ||
| Q3 25 | -35.9% | -6.6% | ||
| Q2 25 | -15.4% | -8.0% | ||
| Q1 25 | -62.2% | -37.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | -0.9% | ||
| Q2 24 | -83.9% | -56.7% | ||
| Q1 24 | 44.3% | -27.8% |
每股收益（稀释后）ESPRSHIM
| Q4 25 | $0.32 | $-0.12 | ||
| Q3 25 | $-0.16 | $-0.25 | ||
| Q2 25 | $-0.06 | $-0.28 | ||
| Q1 25 | $-0.21 | $-0.92 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | $-0.05 | ||
| Q2 24 | $-0.33 | $-1.83 | ||
| Q1 24 | $0.34 | $-1.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $17.6M |
| 总债务越低越好 | — | $57.5M |
| 股东权益账面价值 | $-302.0M | $-52.7M |
| 总资产 | $465.9M | $218.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRSHIM
| Q4 25 | $167.9M | $17.6M | ||
| Q3 25 | $92.4M | $21.4M | ||
| Q2 25 | $86.1M | $16.3M | ||
| Q1 25 | $114.6M | $33.7M | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | $26.0M | ||
| Q2 24 | $189.3M | $22.4M | ||
| Q1 24 | $226.6M | $27.3M |
总债务ESPRSHIM
| Q4 25 | — | $57.5M | ||
| Q3 25 | — | $36.4M | ||
| Q2 25 | — | $31.4M | ||
| Q1 25 | — | $9.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $39.9M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $31.5M |
股东权益ESPRSHIM
| Q4 25 | $-302.0M | $-52.7M | ||
| Q3 25 | $-451.4M | $-49.5M | ||
| Q2 25 | $-433.5M | $-42.6M | ||
| Q1 25 | $-426.2M | $-34.7M | ||
| Q4 24 | $-388.7M | — | ||
| Q3 24 | $-370.2M | $973.0K | ||
| Q2 24 | $-344.2M | $436.0K | ||
| Q1 24 | $-294.3M | $38.1M |
总资产ESPRSHIM
| Q4 25 | $465.9M | $218.5M | ||
| Q3 25 | $364.0M | $203.0M | ||
| Q2 25 | $347.1M | $227.7M | ||
| Q1 25 | $324.0M | $233.9M | ||
| Q4 24 | $343.8M | — | ||
| Q3 24 | $314.1M | $346.7M | ||
| Q2 24 | $352.3M | $344.5M | ||
| Q1 24 | $373.1M | $378.0M |
负债/权益比ESPRSHIM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 41.01× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $-23.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-28.7M |
| 自由现金流率自由现金流/营收 | — | -20.2% |
| 资本支出强度资本支出/营收 | 0.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-27.2M |
8季度趋势，按日历期对齐
经营现金流ESPRSHIM
| Q4 25 | $45.2M | $-23.7M | ||
| Q3 25 | $-4.3M | $-3.8M | ||
| Q2 25 | $-31.4M | $-38.2M | ||
| Q1 25 | $-22.6M | $44.9M | ||
| Q4 24 | $-35.0M | — | ||
| Q3 24 | $-35.3M | $12.7M | ||
| Q2 24 | $-7.2M | $-43.9M | ||
| Q1 24 | $53.8M | $-35.0M |
自由现金流ESPRSHIM
| Q4 25 | — | $-28.7M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-38.7M | ||
| Q1 25 | — | $44.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | $10.3M | ||
| Q2 24 | $-7.3M | $-46.8M | ||
| Q1 24 | $53.8M | $-39.6M |
自由现金流率ESPRSHIM
| Q4 25 | — | -20.2% | ||
| Q3 25 | — | -3.2% | ||
| Q2 25 | — | -31.7% | ||
| Q1 25 | — | 42.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | 6.2% | ||
| Q2 24 | -9.9% | -51.7% | ||
| Q1 24 | 39.0% | -33.0% |
资本支出强度ESPRSHIM
| Q4 25 | 0.0% | 3.5% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.5% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | 1.4% | ||
| Q2 24 | 0.1% | 3.3% | ||
| Q1 24 | 0.1% | 3.8% |
现金转化率ESPRSHIM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SHIM
| Shimmick Projects | $106.8M | 75% |
| Non Core Projects | $35.1M | 25% |
